Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VALIC Company I Health Sciences Fund (VCHSX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital growth. The fund normally invests at least 80% of net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). It can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-cap companies. The fund may invest up to 35% of its total assets in foreign stocks, which include non-dollar denominated securities traded outside the U.S.


1 month-7.22% 3 years+25.83%
3 months-12.79% 5 years+27.02%
1 year+16.35% Since inception+12.04%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+27.02%+20.66%
Expense ratio1.11%1.39%
Risk 5 year sharpe ratio1.971.38
Net assets$921.0M$3.8B
Average market cap$25.0B$33.2B
Average P/E25.124.4
Portfolio turnover26%26%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVALIC
Fund manager & tenureTaymour Tamaddon / 2 Years
Minimal initial investment$0.00
Minimum IRA investment--


U.S. stock79.39%
International stock14.54%
Fixed income0.17%
Top 5 Sectors
Portfolio weighting
Healthcare 93.57%
Consumer service 1.09%
Industrial materials 0.89%
Financial service 0.35%
Hardware 0.19%
Top 10 Holdings
Portfolio weighting
AGN Allergan5.28%
ALXN Alexion Pharmaceuticals Inc4.11%
-- 4.07%
CI Cigna Corp3.86%
GILD Gilead Sciences3.21%
UNH UnitedHealth3.21%
AET Aetna2.90%
MCK McKesson Corp2.78%
ABBV AbbVie2.26%
HUM Humana Inc2.24%

Partner Offers